Debrisoquine

This classification denotes an adrenergic agent, antihypertensive agent, and sympatholytic with the molecular formula C10H13N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X31CDK040E, chemically known as 1,2,3, 4-tetrahydro-isoquinoline-2-carboxamidine sulfate but generally known as debrisoquine, which bears US NIH Compound Identifier 2966. European Medicines Agency schedules Debrisoquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06928MIG. World Health Organization schedules debrisoquine in its Anatomical Therapeutic Chemical (ATC) Classification. DEBRISOQUINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule debrisoquine under HS 29334990 and SITC 51575. SMILES: C1CN(CC2=CC=CC=C21)C(=N)N.